These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8541433)

  • 21. Flumazenil in benzodiazepine antagonism. Actions and clinical use in intoxications and anaesthesiology.
    Amrein R; Leishman B; Bentzinger C; Roncari G
    Med Toxicol Adverse Drug Exp; 1987; 2(6):411-29. PubMed ID: 2893240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Which agent and how to deliver it? A review of benzodiazepine sedation and its reversal in endoscopy.
    McCloy RF; Pearson RC
    Scand J Gastroenterol Suppl; 1990; 179():7-11. PubMed ID: 1981104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flumazenil (Ro 15-1788) and physostigmine.
    Lauven PM; Stoeckel H
    Resuscitation; 1988; 16 Suppl():S41-8. PubMed ID: 2849177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antagonist or antidote?].
    Saint-Maurice C
    Cah Anesthesiol; 1995; 43(4):341-2. PubMed ID: 8564650
    [No Abstract]   [Full Text] [Related]  

  • 25. Anaesthesia for the patient with dementia undergoing outpatient surgery.
    Funder KS; Steinmetz J; Rasmussen LS
    Curr Opin Anaesthesiol; 2009 Dec; 22(6):712-7. PubMed ID: 19734784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antagonism of flunitrazepam and fentanyl by flumazenil, naloxone or nalbuphine].
    Schaer H; Baasch K; Achtari R
    Anaesthesist; 1990 Jan; 39(1):26-32. PubMed ID: 2106274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Forced opioid detoxification under general anesthesia--a new challenge for anesthetists and intensive care physicians].
    Hensel M; Volk T; Kox WJ
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):261-8. PubMed ID: 10372215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of benzodiazepine overdose with flumazenil. The Flumazenil in Benzodiazepine Intoxication Multicenter Study Group.
    Clin Ther; 1992; 14(6):978-95. PubMed ID: 1286503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal Agents in Sedation and Anesthesia Practice for Dentistry.
    Wong M
    Anesth Prog; 2022 Apr; 69(1):49-58. PubMed ID: 35377935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of enteral naloxone for the reversal of opiate-induced constipation in the intensive care unit.
    Arpino PA; Thompson BT
    J Clin Pharm Ther; 2009 Apr; 34(2):171-5. PubMed ID: 19250137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of flumazenil versus physostigmine after midazolam-alfentanil anaesthesia in man.
    Breimer LT; Hennis PJ; Bovill JG; Spierdijk J
    Eur J Anaesthesiol Suppl; 1988; 2():109-16. PubMed ID: 2900756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central anticholinergic syndrome strikes again.
    Cohen S; Hunter CW; Yanni B; Striker P; Hijazi RH
    J Clin Anesth; 2006 Aug; 18(5):399-400. PubMed ID: 16905092
    [No Abstract]   [Full Text] [Related]  

  • 33. Reversal of the central effects of midazolam by intravenous flumazenil after general anesthesia and use of a long-acting opioid in hospitalized patients: report of a multicenter double-blind clinical study. The Flumazenil in General Anesthesia in Hospitalized Patients Study Group II.
    Clin Ther; 1992; 14(6):939-53. PubMed ID: 1286500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiorespiratory effects of naloxone in children.
    Hasan RA; Benko AS; Nolan BM; Campe J; Duff J; Zureikat GY
    Ann Pharmacother; 2003 Nov; 37(11):1587-92. PubMed ID: 14565809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pharmacology of antagonists of narcotic-induced respiratory depression. A brief review.
    Bowdle TA
    Acute Care; 1988; 12 Suppl 1():70-6. PubMed ID: 3278495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of enteral naloxone and i.v. neostigmine when used to relieve constipation.
    Thomas MC; Erstad BL
    Am J Health Syst Pharm; 2003 Jun; 60(12):1264-7. PubMed ID: 12845923
    [No Abstract]   [Full Text] [Related]  

  • 37. [Combination of morphine with low-dose naloxone for intravenous patient-controlled analgesia].
    Zhao LY; Ye TH; Zhang YZ; Zhao H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Apr; 27(2):228-31. PubMed ID: 15960271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. National survey of the use of sedating drugs, neuromuscular blocking agents, and reversal agents in the intensive care unit.
    Rhoney DH; Murry KR
    J Intensive Care Med; 2003; 18(3):139-45. PubMed ID: 14984632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experience in the use of a benzodiazepine antagonist, flumazenil].
    Vabishchevich AV; Buniatian AA; Stamov VI; Kochneva ZV
    Anesteziol Reanimatol; 1997; (5):95-8. PubMed ID: 9432903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal flumazenil and naloxone to reverse over-sedation in a child undergoing dental restorations: comment.
    Zanette G; Favero L; Manani G; Facco E
    Paediatr Anaesth; 2010 Jan; 20(1):109. PubMed ID: 19930110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.